Global Medical Tubing Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Material (Polyvinyl Chloride, Polyethylene, Polypropylene, Silicone Polymers, Bioabsorbable Polymers, Others), By Structure (Single Lumen, Multiple Lumen, Co-Extruded, Tapered/Bump Tubing, Braided Tubing, Balloon Tubing, Heat Shrink Tubing), By Application (Drug Delivery, Dialysis, Intravenous (IV), Catheters, Feeding Tubes, Biopharma Lab Equipment, Others), And By Geography- Forecasts From 2022 To 2027

The global medical tubing market is estimated to grow at a CAGR of 10.90% to reach a market size of US$9.575 billion in 2027 from US$4.642 billion in 2020.

Medical tubing holds an important role in the medical industry. It is used for a variety of applications for fluid management and drainage, among others. Also, medical tubing is utilized in pharmaceutical laboratory equipment applications. The growing medical industry is burgeoning demand in the market in the forecast period. The government’s investments to provide better healthcare facilities worldwide are further driving market growth over the next five years. The increasing prevalence of chronic diseases, and the presence of the older population at the global level, above 65 years of age, are further fueling the market growth in the forecast period. There is a high prevalence of people diagnosed with heart disease. According to the World Health Organization (WHO), 17.9 million people die each year due to cardiovascular diseases (CVDs), an estimated 31% of all deaths worldwide. Increasing consumption of tobacco, an unhealthy diet, and physical inactivity are raising the risk of heart attacks and strokes. According to Centres for Disease Control and Prevention, heart disease has been the major cause of death in the United States, with coronary heart disease being the most common type of heart disease. Obesity is one of the major causes of heart attacks.  All these factors are driving the growth of the medical tubing market across the globe with the surging number of cardiac patients.

Medical professionals are focusing on a combination of risk factors for these diseases, implementing medical screening for the individuals at risk, and then providing effective treatment to prevent disability and death while improving quality of life. Many cardiac devices are designed to help control the irregular heartbeats of patients with heart rhythm disorders. The rising elderly population is boosting the demand for various efficient healthcare facilities. This is because this demographic shift is putting a burden on health expenditure worldwide, further increasing the growth prospects of the medical tubing market in the forecast period. Factors such as increased life expectancy and declining fertility are the key factors behind the growing aged population across the globe. According to the United Nations statistics, the number of people aged 60 years or above is projected to increase from 962.3 million in 2017 to 2,080.5 million by 2050. Since aged people are most susceptible to diseases, the demand for medical tubing holds strong growth chances.  Thus, this is estimated to have a positive impact on the market growth in the forecast period and the upcoming years.

The growing polymer industry is significantly contributing to the market growth with a huge application of polymers in healthcare. Furthermore, with the growing drug delivery industry, the market is propelled to grow with high application in targeted drug delivery. Moreover, with the growing adoption of minimally invasive surgical procedures, the market is projected to grow at a significant pace in the forecast period and in the upcoming years. Geographically, North America is projected to hold a significant market share, followed by the European region. The Asia Pacific region is projected to be the fastest-growing in the forecast period owing to the favourable government initiatives for providing better healthcare facilities in the region.

The presence of dedicated healthcare services, which include remote patient monitoring and management, is driving the market demand in the forecast period.

Remote patient monitoring refers to keeping a track of a patient’s health even when outside the conventional clinical settings (at home). It is highly helpful in the case of patients suffering from chronic diseases like CVDs who may require access to care, which may eventually decrease healthcare delivery costs. Effective monitoring while at home; trend analysis of physiological parameters; early detection of any deviation from a normal condition; and a reduction in the number of emergency visits and hospital stay duration are key features.  This further allocates enough time for healthcare providers to connect and communicate well with their patients. Patients with complex diseases such as heart diseases are provided with a mobile phone and commercial home-based medical devices for measurements like blood pressure monitoring, weight monitoring, and others. In case of any abnormality, an alert is sent to the concerned clinicians and the patient, and the necessary action is taken care of accordingly.

Healthcare facilities, based on disease severity, are provided to the patients.  These include primary, secondary, tertiary, and quaternary care. Secondary and tertiary care is required for the treatment of serious illnesses, while, the quaternary is an extension of tertiary care and is less prevalent than the other services. These deliver specialized and advanced services for highly specialized treatments and care.

The growing drug delivery industry is driving the market demand where the key market players with certain strategic objectives are developing innovative drug delivery systems, further propelling the market growth in the forecast period.

The companies’ key strategic priorities and objectives include: achieving scientific leadership by focusing science on three therapy areas and accelerating the pipeline, in addition to transforming the way of working, returning to growth by focusing on the growth platforms and transforming the business through speciality care, devices, and biologic medicines; a targeted business development which strengthens the company’s efforts, to be a great place to work. This will be achieved by evolving company culture and simplifying company business. Furthermore, the companies aim to attract and retain the best talent, in addition, to doing business sustainably and achieving group financial targets. Increasing revenue growth by focusing on the company’s core products, services, and solutions that deliver greater benefits to patients, healthcare workers, and researchers. Supplementing the company’s internal growth through strategic acquisitions. Continued investments in research and development for platform extensions and innovative new products, to make investments in growing company operations in emerging markets, improving operating effectiveness and balance sheet productivity, in addition to driving an efficient capital structure and strong shareholder returns. The strengthening of category leadership, expansion into high growth adjacencies, to drive global expansion, fund the journey to fuel growth, and the development of key capabilities. The execution of these strategic imperatives is poised to drive innovation, accelerate profitable revenue growth, and increase stockholder value, in addition to bolstering the company’s leadership position in the medical device industry.

Recent Developments and expansions

• MS Techniques & Transluminal, a high-precision thermoplastic extrusion, and developer of minimally invasive catheter systems, was acquired by Saint-Gobain SA in September 2020. The acquired firm was incorporated into Saint-Gobain SA's Life Sciences Medical Components business area as a result of this acquisition. Saint-Gobain SA benefited from this acquisition in the market for minimally invasive medical procedures.
• Freudenberg Medical, LLC expanded its manufacturing activities in Alajuela, Costa Rica, in May 2021. 8,600 square feet of facility space were added to the current facility as part of this extension project. The company's capacity for moulding, extrusion, packaging and catheter manufacturing & assembly was increased as a result of the expansion.
• HelixFlexTM, a high-purity thermoplastic elastomer TPE tubing intended to be used in pharmaceutical and biotechnology applications, was introduced in May 2022 by Freudenberg Medical, a producer of medical and pharmaceutical equipment, components, and tubing. Freudenberg is extending its current offering and adding this to its array of pharma products.

COVID-19 Impact on Medical Tubing Market

The medical tubing market was impacted favourably by COVID-19. The pandemic led to an increase in the usage of medical gadgets in the healthcare sector. The pandemic is expected to cause the medical tubing business to expand at a never-before-seen pace. The need for IV tubes, breathing tubes, and drug delivery tubes has increased, among other things. Due to the COVID-19 pandemic's high contagiousness, hospitals in the US lengthened their IV tubing so they could be placed outside of patient rooms.

Segmentation:

• By Material
  • Polyvinyl Chloride
  • Polyethylene
  • Polypropylene
  • Silicone Polymers
  • Bioabsorbable Polymers
  • Others
• By Structure
  • Single Lumen
  • Multiple Lumen
  • Co-Extruded
  • Tapered/ Bump Tubing
  • Braided Tubing
  • Balloon Tubing
  • Heat Shrink Tubing
• By Application
  • Drug Delivery
  • Dialysis
  • Intravenous (IV)
  • Catheters
  • Feeding Tubes
  • Biopharma lab equipment
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Others
  • Middle East and Africa
    • UAE
    • Israel
    • Saudi Arabia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others